BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin Z, Lu Y, Meng Q, Wang C, Li X, Yang Y, Xin X, Zheng Q, Xu J, Gui X, Li T, Pu H, Xiong W, Li J, Jia S, Lu D. miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1. Mol Ther Nucleic Acids 2018;11:494-507. [PMID: 29858084 DOI: 10.1016/j.omtn.2018.04.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang L, Wang P, Su X, Zhao B. Circ_0001658 promotes the proliferation and metastasis of osteosarcoma cells via regulating miR‐382‐5p/YB‐1 axis. Cell Biochem Funct 2020;38:77-86. [DOI: 10.1002/cbf.3452] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
2 Puckett DL, Alquraishi M, Chowanadisai W, Bettaieb A. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs. Int J Mol Sci 2021;22:1171. [PMID: 33503959 DOI: 10.3390/ijms22031171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Ding Y, Li Y, Duan Y, Wang W, Zheng W, Cheng W, Qi Y, Feng J, Chen Z, Yu T, Hu A, Wang T, Li M, Zhang H, Li Y, Ma F, Guo B, Sagar V. LncRNA MBNL1-AS1 Represses Proliferation and Cancer Stem-Like Properties of Breast Cancer through MBNL1-AS1/ZFP36/CENPA Axis. Journal of Oncology 2022;2022:1-22. [DOI: 10.1155/2022/9999343] [Reference Citation Analysis]
4 Alkrekshi A, Wang W, Rana PS, Markovic V, Sossey-Alaoui K. A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance. Cell Signal 2021;85:110073. [PMID: 34224843 DOI: 10.1016/j.cellsig.2021.110073] [Reference Citation Analysis]
5 Gong H, Gao S, Yu C, Li M, Liu P, Zhang G, Song J, Zheng J. Effect and mechanism of YB-1 knockdown on glioma cell growth, migration, and apoptosis. Acta Biochim Biophys Sin (Shanghai) 2020;52:168-79. [PMID: 32047913 DOI: 10.1093/abbs/gmz161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yang Y, Song S, Meng Q, Wang L, Li X, Xie S, Chen Y, Jiang X, Wang C, Lu Y, Xin X, Pu H, Gui X, Li T, Xu J, Li J, Jia S, Lu D. miR24-2 accelerates progression of liver cancer cells by activating Pim1 through tri-methylation of Histone H3 on the ninth lysine. J Cell Mol Med 2020;24:2772-90. [PMID: 32030886 DOI: 10.1111/jcmm.15030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wang C, Zeng J, Li LJ, Xue M, He SL. Cdc25A inhibits autophagy-mediated ferroptosis by upregulating ErbB2 through PKM2 dephosphorylation in cervical cancer cells. Cell Death Dis 2021;12:1055. [PMID: 34743185 DOI: 10.1038/s41419-021-04342-y] [Reference Citation Analysis]
8 Chen ZG, Zheng CY, Cai WQ, Li DW, Ye FY, Zhou J, Wu R, Yang K. miR-26b Mimic Inhibits Glioma Proliferation In Vitro and In Vivo Suppressing COX-2 Expression. Oncol Res 2019;27:147-55. [PMID: 28800785 DOI: 10.3727/096504017X15021536183517] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
9 Yu H, He J, Liu W, Feng S, Gao L, Xu Y, Zhang Y, Hou X, Zhou Y, Yang L, Wang X. The Transcriptional Coactivator, ALL1-Fused Gene From Chromosome 9, Simultaneously Sustains Hypoxia Tolerance and Metabolic Advantages in Liver Cancer. Hepatology 2021. [PMID: 33928666 DOI: 10.1002/hep.31870] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Arora S, Joshi G, Chaturvedi A, Heuser M, Patil S, Kumar R. A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2. J Med Chem 2021. [PMID: 34726055 DOI: 10.1021/acs.jmedchem.1c00981] [Reference Citation Analysis]
11 Tong H, Zhao K, Zhang J, Zhu J, Xiao J. YB-1 modulates the drug resistance of glioma cells by activation of MDM2/p53 pathway. Drug Des Devel Ther 2019;13:317-26. [PMID: 30679904 DOI: 10.2147/DDDT.S185514] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
12 Mordovkina D, Lyabin DN, Smolin EA, Sogorina EM, Ovchinnikov LP, Eliseeva I. Y-Box Binding Proteins in mRNP Assembly, Translation, and Stability Control. Biomolecules 2020;10:E591. [PMID: 32290447 DOI: 10.3390/biom10040591] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
13 Wang C, Jiang X, Li X, Song S, Meng Q, Wang L, Lu Y, Xin X, Pu H, Gui X, Li T, Lu D. Long noncoding RNA HULC accelerates the growth of human liver cancer stem cells by upregulating CyclinD1 through miR675-PKM2 pathway via autophagy. Stem Cell Res Ther 2020;11:8. [PMID: 31900225 DOI: 10.1186/s13287-019-1528-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
14 Klec C, Gutschner T, Panzitt K, Pichler M. Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention. Expert Opin Ther Targets 2019;23:177-86. [PMID: 30678498 DOI: 10.1080/14728222.2019.1570499] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
15 Tao T, Wu S, Sun Z, Ma W, Zhou S, Deng J, Su Q, Peng M, Xu G, Yang X. The molecular mechanisms of LncRNA-correlated PKM2 in cancer metabolism. Biosci Rep 2019;39:BSR20192453. [PMID: 31654067 DOI: 10.1042/BSR20192453] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]